Michael M. Derkacz

Director Ejecutivo en BRAEBURN INC. .

56 años

Health Technology

Consumer Services

Commercial Services

Cargos activos de Michael M. Derkacz

Empresas	Cargo	Inicio	Fin
BRAEBURN INC.	Director/Miembro de la Junta	05/06/2017	-
	Director Ejecutivo	05/06/2017	-
	Presidente	05/06/2017	-

Empresas	Cargo	Inicio	Fin
AUSPEX PHARMACEUTICALS INC	Corporate Officer/Principal	05/05/2015	-
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Corporate Officer/Principal	-	-
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Corporate Officer/Principal	01/01/2011	-

The University of Texas at Austin

Undergraduate Degree

Internacional

Estados Unidos	5
Israel	2

Operativa

Corporate Officer/Principal	3
Undergraduate Degree	1
Director/Board Member	1

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Health Technology

Empresas privadas	3
Auspex Pharmaceuticals, Inc. Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA.	Health Technology
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Health Technology
Braeburn, Inc. Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ.	Commercial Services